The stablecoin giant launches MiningOS, a modular platform designed to democratize Bitcoin mining operations from home setups to industrial facilities, challenging the proprietary software dominance in the sector.
Tenet Healthcare has finalized a complex $2.65 billion transaction restructuring its Conifer unit's long-standing contract with CommonSpirit Health. The deal bolsters Tenet's cash flow, returns full control of Conifer, and sets the stage for accelerated share repurchases and investments in automation and AI-driven efficiency.
Snowflake CEO Sridhar Ramaswamy addresses investor fears that AI will disrupt traditional software firms, arguing data platforms are uniquely positioned for growth as his company announces a major new deal with OpenAI.
Following its latest dividend increase, we break down the investment required to generate a steady $1,000 yearly income from Brookfield Renewable, comparing the tax implications and yields of its two share classes.
Former President Donald Trump stated he was unaware of a major investment by an Abu Dhabi royal into World Liberty Financial, a crypto platform he co-founded. The deal, struck just before his inauguration, has reignited debates over foreign influence and the blurring lines between presidential family business and public office.
Airbus CEO Guillaume Faury warns that persistent supply chain disruptions, particularly for engines, will challenge aircraft deliveries through 2026, even as defense demand rises and competition from China's Comac grows.
Despite a soaring share price, Keppel Ltd's return on capital employed remains low and static, suggesting the conglomerate may be past its high-growth phase and reliant on dividends to reward shareholders.
A new intrinsic value analysis of Moonpig Group PLC suggests the online greeting card retailer's stock may be trading at a significant discount to its fair value, based on projected future cash flows.
While gold and silver prices plunged from record highs, positioning data reveals institutional investors had already begun rotating capital out of precious metals and into energy futures in the preceding weeks.
Bitcoin's attempt to stabilize above $75,000 faces a new headwind as the U.S. dollar index posts its strongest two-day rally in nearly a year, casting doubt on the sustainability of any crypto rebound.
A critical deadline for retirement account withdrawals is fast approaching for a specific cohort. Missing it could trigger a severe tax penalty, making advance planning essential for those affected.
Chinese President Xi Jinping and Uruguay's President Yamandú Orsi have elevated their strategic partnership, signing a raft of new agreements. The meeting, emphasizing an "equal and orderly multipolar world," underscores China's diplomatic push in Latin America following recent regional instability.
China becomes the first nation to regulate against concealed automotive door handles, a feature popularized by Tesla and adopted by other EV makers, citing safety concerns in emergency situations. The new standards take effect in 2027.
After a sharp recent pullback, Palantir Technologies' lofty valuation is under the microscope. While its long-term growth narrative remains compelling, traditional metrics suggest the stock may be pricing in near-perfect execution. We examine the numbers behind the debate.
Vaxcyte's shares have surged over 23% in the past month, sparking debate among investors. While a discounted cash flow model suggests significant upside, traditional metrics paint a more cautious picture. We examine the numbers and the narratives driving this biotech stock.
AT&T makes two significant strategic moves, acquiring Lumen's fiber assets to expand its broadband footprint and partnering to launch a network-based fall detection device for seniors, as it seeks to leverage its core infrastructure for future growth.
Coca-Cola shares have gained nearly 9% in the past month, buoyed by anticipation of its upcoming earnings report and a looming leadership transition. Analysts are divided on whether the iconic beverage giant's current valuation fully reflects its steady dividends and global brand strength.
Keysight Technologies' shares have climbed sharply, gaining 26.6% over the past year. As the stock trades near $223, investors are grappling with a critical question: does its current price reflect its true value, or has momentum pushed it into overvalued territory? A deep dive into key valuation metrics suggests caution may be warranted.
Shares of USA Rare Earth (USAR) have skyrocketed over 56% in the past month, defying its reported zero revenue and substantial losses. As the critical minerals sector heats up, investors are left to question whether this is speculative frenzy or a bet on a strategic national resource.
The U.S. Food and Drug Administration has removed a clinical hold on Intellia Therapeutics' pivotal Phase 3 study of its gene-editing candidate for a rare, progressive disease, allowing the trial to proceed with enhanced safety monitoring. The move refocuses investor attention on the company's pipeline and long-term valuation prospects.
